Thirty-seven clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus and three type or reference strains of the species were studied with respect to vancomycin susceptibility and key identification characteristics. With the exception of one clinical isolate of E. casseliflavus (MIC, 4 ,ug/ml), MICs of vancomycin were 8 to 32 ,ug/ml. The type strain of E. gallinarum, NCDO 2313, and 
The first report of vancomycin-resistant Enterococcus gallinarum was published in 1988 (8) . Recent data from the Centers for Disease Control suggest that E. gallinarum is less susceptible to vancomycin than other enterococci (11) . Including the type strains, we have examined 23 isolates of E. gallinarum and 17 isolates of Enterococcus casseliflavus, all but one of which were more resistant to vancomycin than other enterococci, with MICs of vancomycin ranging from 8 to 32 ,ug/ml.
Bacterial strains. E. gallinarum strains used were NCDO 2313T (2, 4); ATCC 35038 (said to be the same as NCDO 2313); three former clinical isolates, UCLA I, UCLA II, and SC I; 11 additional isolates from liver transplant patients in Pittsburgh, Pa. (LT strains); and 9 isolates (G strains) from patients at the University of Chicago. The three former clinical isolates have been described previously (12) (9) , and Enterococcus faecalis JH2-2 (6) have been previously described. Enterococcus raffinosus 785B and E. faecium 1006D (both penicillin resistant) were recently described (1 Vancomycin susceptibilities were determined by diluting the antibiotics through agar, as recommended by the National Committee for Clinical Laboratory Standards, except that brain heart infusion agar replaced Mueller-Hinton agar (10) . Teicoplanin susceptibilities were determined on the basis of either agar dilution MICs, as described above, or macrobroth dilution, as recommended by the National Committee for Clinical Laboratory Standards (10 (13) , except that the films were not prefogged. The results are shown in Fig. 1 (9) . DNA homologies were determined by using 51 nuclease in solution under optimal conditions for hybridization (9 
